Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550109145> ?p ?o ?g. }
- W2550109145 endingPage "178.e9" @default.
- W2550109145 startingPage "178.e1" @default.
- W2550109145 abstract "We investigated a CAG trinucleotide repeat expansion in the ATXN2 gene in amyotrophic lateral sclerosis (ALS). Two new case-control studies, a British dataset of 1474 ALS cases and 567 controls, and a Dutch dataset of 1328 ALS cases and 691 controls were analyzed. In addition, to increase power, we systematically searched PubMed for case-control studies published after 1 August 2010 that investigated the association between ATXN2 intermediate repeats and ALS. We conducted a meta-analysis of the new and existing studies for the relative risks of ATXN2 intermediate repeat alleles of between 24 and 34 CAG trinucleotide repeats and ALS. There was an overall increased risk of ALS for those carrying intermediate sized trinucleotide repeat alleles (odds ratio 3.06 [95% confidence interval 2.37-3.94]; p = 6 × 10-18), with an exponential relationship between repeat length and ALS risk for alleles of 29-32 repeats (R2 = 0.91, p = 0.0002). No relationship was seen for repeat length and age of onset or survival. In contrast to trinucleotide repeat diseases, intermediate ATXN2 trinucleotide repeat expansion in ALS does not predict age of onset but does predict disease risk." @default.
- W2550109145 created "2016-11-30" @default.
- W2550109145 creator A5001477192 @default.
- W2550109145 creator A5002628021 @default.
- W2550109145 creator A5004501662 @default.
- W2550109145 creator A5006492716 @default.
- W2550109145 creator A5011302176 @default.
- W2550109145 creator A5011932191 @default.
- W2550109145 creator A5013023361 @default.
- W2550109145 creator A5013899525 @default.
- W2550109145 creator A5018383005 @default.
- W2550109145 creator A5020514779 @default.
- W2550109145 creator A5022091308 @default.
- W2550109145 creator A5024051587 @default.
- W2550109145 creator A5029095625 @default.
- W2550109145 creator A5035328974 @default.
- W2550109145 creator A5038119270 @default.
- W2550109145 creator A5038725564 @default.
- W2550109145 creator A5039639102 @default.
- W2550109145 creator A5042566383 @default.
- W2550109145 creator A5048408999 @default.
- W2550109145 creator A5053155119 @default.
- W2550109145 creator A5054206487 @default.
- W2550109145 creator A5057035079 @default.
- W2550109145 creator A5057953137 @default.
- W2550109145 creator A5058523077 @default.
- W2550109145 creator A5060491124 @default.
- W2550109145 creator A5061518639 @default.
- W2550109145 creator A5061853919 @default.
- W2550109145 creator A5061919060 @default.
- W2550109145 creator A5062092102 @default.
- W2550109145 creator A5064612611 @default.
- W2550109145 creator A5066743272 @default.
- W2550109145 creator A5067433680 @default.
- W2550109145 creator A5069816083 @default.
- W2550109145 creator A5070233617 @default.
- W2550109145 creator A5071383564 @default.
- W2550109145 creator A5072103383 @default.
- W2550109145 creator A5074077702 @default.
- W2550109145 creator A5074593768 @default.
- W2550109145 creator A5075875415 @default.
- W2550109145 creator A5076198690 @default.
- W2550109145 creator A5081473300 @default.
- W2550109145 creator A5082274535 @default.
- W2550109145 creator A5082719446 @default.
- W2550109145 creator A5084783422 @default.
- W2550109145 creator A5087989608 @default.
- W2550109145 creator A5091192587 @default.
- W2550109145 creator A5091904941 @default.
- W2550109145 date "2017-03-01" @default.
- W2550109145 modified "2023-10-15" @default.
- W2550109145 title "ATXN2 trinucleotide repeat length correlates with risk of ALS" @default.
- W2550109145 cites W1963989418 @default.
- W2550109145 cites W1971047357 @default.
- W2550109145 cites W1981430724 @default.
- W2550109145 cites W1983960237 @default.
- W2550109145 cites W1985093325 @default.
- W2550109145 cites W1994430741 @default.
- W2550109145 cites W2000984052 @default.
- W2550109145 cites W2008213051 @default.
- W2550109145 cites W2010652292 @default.
- W2550109145 cites W2012093225 @default.
- W2550109145 cites W2015805588 @default.
- W2550109145 cites W2016332933 @default.
- W2550109145 cites W2020611231 @default.
- W2550109145 cites W2025452604 @default.
- W2550109145 cites W2028582698 @default.
- W2550109145 cites W2050626075 @default.
- W2550109145 cites W2068096553 @default.
- W2550109145 cites W2070043048 @default.
- W2550109145 cites W2071732376 @default.
- W2550109145 cites W2081974513 @default.
- W2550109145 cites W2089632640 @default.
- W2550109145 cites W2089763487 @default.
- W2550109145 cites W2093258646 @default.
- W2550109145 cites W2098935457 @default.
- W2550109145 cites W2106707821 @default.
- W2550109145 cites W2107446322 @default.
- W2550109145 cites W2109646678 @default.
- W2550109145 cites W2113792524 @default.
- W2550109145 cites W2116475791 @default.
- W2550109145 cites W2119506231 @default.
- W2550109145 cites W2123331715 @default.
- W2550109145 cites W2125096332 @default.
- W2550109145 cites W2132539907 @default.
- W2550109145 cites W2133305315 @default.
- W2550109145 cites W2134965790 @default.
- W2550109145 cites W2138543778 @default.
- W2550109145 cites W2159284401 @default.
- W2550109145 cites W2162922234 @default.
- W2550109145 cites W2170670132 @default.
- W2550109145 cites W2477863367 @default.
- W2550109145 cites W2576440140 @default.
- W2550109145 cites W2588681363 @default.
- W2550109145 doi "https://doi.org/10.1016/j.neurobiolaging.2016.11.010" @default.
- W2550109145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5302215" @default.
- W2550109145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28017481" @default.
- W2550109145 hasPublicationYear "2017" @default.